|
原发性肝癌的肝外转移临床特点及危险因素
|
Abstract:
原发性肝癌是一种临床极为常见的恶性肿瘤,因无特异性症状,早期诊断十分困难。大部分患者在初次确诊时疾病已进展至中晚期,预后欠佳。原发性肝癌出现肝外转移是导致患者预后欠佳的重要因素。在早期原发性肝癌肝外转移的研究中,文献数据来源多基于案例报道及尸检报告。在21世纪初期,有了小样本量的原发性肝癌肝外转移危险因素研究。近年来,已有大量文献报道MVI、sERBB3、miR-214、IL-8等可以预测原发性肝癌肝外转移的风险,但少有基于临床可获得的常规数据来预测原发性肝癌肝外转移的危险因素。本文旨在回顾原发性肝癌肝外转移相关文献,对原发性肝癌肝外转移临床特点及危险因素进行总结。
Primary hepatocellular carcinoma is an extremely common malignant tumour in clinical practice. As there are no specific symptoms, early diagnosis is very difficult, and most patients have progressed to the middle and late stages of the disease by the time they are first diagnosed, with a poor prognosis. The presence of extrahepatic metastases in primary liver cancer is an important factor contributing to the poor prognosis of patients. In the study of extrahepatic metastases in early primary liver cancer, the literature is based on case reports and autopsy reports. In the early 21st century, small sample sizes of risk factors for extrahepatic metastases from primary liver cancer have been studied. In recent years, there has been a large body of literature reporting that MVI, sERBB3, miR-214 and IL-8 can predict the risk of extrahepatic metastasis of primary liver cancer, but few risk factors for extrahepatic metastasis of primary liver cancer have been predicted based on clinically available routine data. The aim of this paper is to review the literature related to extrahepatic metastasis of primary liver cancer and to summarize the clinical characteristics and risk factors of extrahepatic metastasis of primary liver cancer.
[1] | Kew, M.C. (2014) Hepatocellular Carcinoma: Epidemiology and Risk Factors. Journal of Hepatocellular Carcinoma, 1, 115-125. https://doi.org/10.2147/JHC.S44381 |
[2] | McGlynn, K., Petrick, J.L. and El-Serag, H.B. (2021) Epidemiology of Hepatocellular Carcinoma. Hepatology, 73, 4-13. https://doi.org/10.1002/hep.31288 |
[3] | Chen, W., Zheng, R., Zhang, S., et al. (2017) Cancer Incidence and Mortality in China, 2013. Cancer Letters, 401, 63-71. https://doi.org/10.1186/s40880-017-0234-3 |
[4] | Ferlay, J., Shin, H., Bray, F., et al. (2010) Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893-2917. https://doi.org/10.1002/ijc.25516 |
[5] | Jemal, A., Bray, F., Center, M.M., et al. (2011) Global Cancer Statistics. Carcinogenesis, 61, 69-90.
https://doi.org/10.3322/caac.20107 |
[6] | Xia, F., Wu, L., Lau, W.Y., et al. (2014) Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis. PLoS ONE, 9, e95889.
https://doi.org/10.1371/journal.pone.0095889 |
[7] | Jo, S. and Shim, H.K. (2013) A Patient Who Has Survived for a Long Period with Repeated Radiotherapies for Multifocal Extrahepatic Metastases from Hepatocellular Carcinoma. Radiation Oncology, 31, 267-272.
https://doi.org/10.3857/roj.2013.31.4.267 |
[8] | Natsuizaka, M., Omura, T., Akaike, T., et al. (2005) Clinical Features of Hepatocellular Carcinoma with Extrahepatic Metastases. Journal of Gastroenterology and Hepatology, 20, 1781-1787.
https://doi.org/10.1111/j.1440-1746.2005.03919.x |
[9] | 杨杰, 曹毅, 江艺, 等. CD44, CD90的表达与肝癌肝移植术后复发转移的关系[J]. 现代肿瘤医学, 2017, 25(19): 3089-3094. |
[10] | Uka, K., Aikata, H., Takaki, S., et al. (2007) Clinical Features and Prognosis of Patients with Extrahepatic Metastases from Hepatocellular Carcinoma. World Journal of Gastroenterology, 13, 414-420.
https://doi.org/10.3748/wjg.v13.i3.414 |
[11] | Uchino, K., Tateishi, R., Shiina, S., et al. (2011) Hepatocellular Carcinoma with Extrahepatic Metastasis: Clinical Features and Prognostic Factors. Cancer, 117, 4475-4483. https://doi.org/10.1002/cncr.25960 |
[12] | 张晓敏, 余吉仙. 首诊乙肝相关原发性肝癌肝外转移危险因素分析[J]. 浙江医学, 2019, 41(22): 2413-2416. |
[13] | 李果, 吴黎雳, 宦宏波, 等. 肝细胞癌肝外转移对患者生存预后的影响[J]. 中华解剖与临床杂志, 2014, 19(4): 307-309. |
[14] | 陈国彬, 黄星, 张真真. 基于SEER数据库的肝细胞肝癌脑转移危险因素分析[J]. 中外医学研究, 2020, 18(13): 12-15. |
[15] | Carr, B.I. and Guerra, V. (2016) Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels. Oncology, 90, 136-142. https://doi.org/10.1159/000443480 |
[16] | Aino, H., Sumie, S., Niizeki, T., et al. (2014) Clinical Characteristics and Prognostic Factors for Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis. Molecular and Clinical Oncology, 2, 393-398.
https://doi.org/10.3892/mco.2014.259 |
[17] | Kanda, M., Tateishi, R., Yoshida, H., et al. (2008) Extrahepatic Metastasis of Hepatocellular Carcinoma: Incidence and Risk Factors. Liver International, 28, 1256-1263. https://doi.org/10.1111/j.1478-3231.2008.01864.x |
[18] | Barr, D.C. and Hussain, H.K. (2014) MR Imaging in Cirrhosis and Hepatocellular Carcinoma. Magnetic Resonance Imaging Clinics of North America, 22, 315-335. https://doi.org/10.1016/j.mric.2014.04.006 |
[19] | Fukumoto, T., Kido, M., Takebe, A., et al. (2017) New Macroscopic Classification and Back-Flow Thrombectomy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Invading the Contralateral Second Portal Branch. Surgery Today, 47, 1094-1103. https://doi.org/10.1007/s00595-017-1507-9 |
[20] | Zhu, K., Chen, J., Lai, L., et al. (2014) Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Treatment with Transarterial Chemoembolization Combined with Sorafenib—A Retrospective Controlled Study. Radiology, 272, 284-293. https://doi.org/10.1148/radiol.14131946 |
[21] | Mittal, S. and El-Serag, H.B. (2013) Epidemiology of Hepatocellular Carcinoma: Consider the Population. Journal of Clinical Gastroenterology, 47, S2-S6. https://doi.org/10.1097/MCG.0b013e3182872f29 |
[22] | Llovet, J.M., Burroughs, A. and Bruix, J. (2003) Hepatocellular Carcinoma. The Lancet, 362, 1907-1917. |
[23] | 刘通, 王万超, 陈思吟, 等. 丙氨酸氨基转移酶水平对原发性肝癌发病风险的预测价值(附95780例报告) [J]. 中华消化外科杂志, 2020, 19(12): 1257-1265. |
[24] | Crasta, J.A., Premlatha, T., Krishnan, S.M., et al. (2010) Significance of Preoperative Thrombocytosis in Epithelial Ovarian Cancer. Indian Journal of Pathology and Microbiology, 53, 54. https://doi.org/10.4103/0377-4929.59184 |
[25] | 陈俊宇, 邱俊, 吴珊, 等. 血小板及其受体促进卵巢癌转移的研究进展[J]. 中国实验诊断学, 2019, 23(7): 1272-1274. |
[26] | Li, M.-M., Yue, C.-X., Fu, S., et al. (2019) Platelet Volume Is Reduced in Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts. Cancer Management and Research, 11, 9067-9072. https://doi.org/10.2147/CMAR.S221976 |
[27] | Li, L., Huang, X.-Y., Li, N., et al. (2019) Platelet Indices in Colorectal Cancer Patients with Synchronous Liver Metastases. Gastroenterology Research and Practice, 2019, Article ID: 6397513. https://doi.org/10.1155/2019/6397513 |
[28] | 毛凯, 王捷. 肝癌合并肝外转移的外科治疗现状[J]. 中华外科杂志, 2019, 57(6): 466-470. |
[29] | Kobayashi, S., Takahashi, S., Kato, Y., et al. (2011) Surgical Treatment of Lymph Node Metastases from Hepatocellular Carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences, 18, 559-566.
https://doi.org/10.1007/s00534-011-0372-y |
[30] | Berger, Y., Spivack, J.H., Heskel, M., Aycart, S.N., Labow, D.M. and Sarpel, U. (2017) Extrahepatic Metastasectomy for Hepatocellular Carcinoma: Predictors of Long-Term Survival. Journal of Surgical Oncology, 115, 505-506.
https://doi.org/10.1002/jso.24555 |
[31] | 王磊, 咸玉涛, 杨正强, 施海彬. 不同治疗方案对晚期肝细胞性肝癌预后的影响及因素分析[J]. 中华介入放射学电子杂志, 2018, 6(2): 104-108. |
[32] | Lee, C.W., Chan, K.M., Lee, C.F., et al. (2011) Hepatic Resection for Hepatocellular Carcinoma with Lymph Node Metastasis: Clinicopathological Analysis and Survival Outcome. Asian Journal of Surgery, 34, 53-62.
https://doi.org/10.1016/S1015-9584(11)60020-1 |
[33] | 叶胜龙. 重视中晚期肝癌的降期转化治疗[J]. 临床肝胆病杂志, 2020, 36(2): 249-251. |
[34] | 耿小平, 周俭, 王征, 等. 肝脏恶性肿瘤合并肝外转移的外科治疗[J]. 中华消化外科杂志, 2019(4): 328-335. |
[35] | 刘少儒, 许磊波. 肝癌肝移植术后复发转移的免疫治疗[J]. 器官移植, 2021, 12(3): 272-279. |
[36] | 伍慧丽, 郑素军, 段钟平. 从解剖学角度探讨原发性肝癌的转移途径[J]. 临床肝胆病杂志, 2017, 33(10): 2009-2015. |
[37] | 秦建民. 转移性肝癌个体化治疗方案的选择与临床意义[J]. 世界华人消化杂志, 2018, 26(29): 1677-1687. |